• OPEN AN ACCOUNT
Indian Indices
Sensex
75,565.82 1,106.29
( 1.49%)
Global Indices
Nasdaq
51,732.40 -631.16
(-1.21%)
Dow Jones
7,581.68 -159.71
(-2.06%)
Hang Seng
63,176.05 -1,483.42
(-2.29%)
Nikkei 225
10,722.51 0.44
(0.00%)
Forex
USD-INR
95.22 0.06
(0.06%)
EUR-INR
106.19 0.24
(0.23%)
GBP-INR
127.01 0.44
(0.35%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Marksans Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524404
INE750C01026
36.4616629
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MARKSANS
43.19
13896.27
EPS(TTM)
Face Value()
Div & Yield %
7.1
1
0.29
 

manappuram finance ltd
UR Sugar Industries standalone net profit declines 50.00% in the March 2026 quarter
May 19,2026
Net profit of UR Sugar Industries declined 50.00% to Rs 0.11 crore in the quarter ended March 2026 as against Rs 0.22 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net profit rose 4.76% to Rs 0.44 crore in the year ended March 2026 as against Rs 0.42 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.